Following a leadership consolidation and the launch of a strategic growth plan last year, F7 Medical’s executive additions strengthen its expertise in five growth areas essential to successful MedTech commercialization.
Factor 7 Medical, a leading consulting and advisory group for medical technology companies, is accelerating its expansion with the addition of five seasoned industry veterans. This strategic move enhances F7M’s ability to support start-up companies, growth stage ventures, and established enterprises in achieving their complex commercialization goals.
“This expansion enables us to serve our clients with even greater depth, ensuring they have the insight, experience, and execution power necessary to bring groundbreaking medical innovations to market.”
Health Technology Insights: iCAD and RamSoft Partner to Expand Profound AI Mammography in North America
With expertise spanning the entire MedTech commercialization lifecycle, the expanded leadership team strengthens F7M’s capabilities across five service areas critical for effective and efficient commercialization of medical innovation: product development; regulatory and quality assurance; operations and supply chain management; sales, marketing and reimbursement strategies; and business and capital formation.
The new team members – each with decades of experience across the MedTech commercialization landscape – bring a new level of trusted expertise and exceptional execution to F7M’s global clientele.
“These industry veterans power up our ability to provide specialized, fractional expertise to MedTech companies at every stage of growth,” said Dan Sands, Founder and Managing Director of F7M. “With this team’s depth of experience, companies can access senior-level guidance in a flexible, cost-effective model—gaining powerful insights that ensure efficient and successful commercialization strategies.”
Health Technology Insights: Volv Global Expands Offices to Advance AI Innovation in Healthcare
“F7M was founded on the principle that MedTech companies need the right expertise at the right time to achieve meaningful growth,” added Bill Phillips, Chairman of the Board. “This expansion enables us to serve our clients with even greater depth, ensuring they have the insight, experience, and execution power necessary to bring groundbreaking medical innovations to market.”
Health Technology Insights: Philips Chooses AWS as Preferred Cloud to Drive Innovation, Patient Care
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – businesswire
